Introduction
The profound roles that TGF ␤ plays during embryogenesis, adult tissue homeostasis, and disease pathogenesis necessitate deeper understanding of mechanisms that regulate this signaling pathway. Signaling occurs via the TGF ␤ type II receptor (T ␤ RII) that trans-phosphorylates T ␤ RI, also known as activin receptor-like kinase (ALK) 5. Activated ALK5 phosphorylates receptor-regulated Smads (Smad2 and Smad3), promotes their association with Smad4, and leads to regulation of transcription ( Feng and Derynck, 2005 ) .
Smad7, a negative regulator of TGF ␤ /Smad signaling, is an immediate early gene target of the pathway (for review see Itoh and ten Dijke, 2007 ) . Smad7 binds to ALK5, competing with Smad2/3 phosphorylation and mediating receptor ubiquitination, mechanisms which link to the process of TGF ␤ receptor internalization and lysosomal degradation ( Di Guglielmo et al., 2003 ) .
We have identified gene targets of Smad signaling ( Kowanetz et al., 2004 ) . A highly regulated gene, SNF1LK ( sucrose nonfermented 1-like kinase ) or salt-inducible kinase 1 ( SIK1 , hereby abbreviated as SIK), encodes a serine/threonine kinase. SIK is one of 14 AMP-activated protein kinases that can be phosphorylated by the tumor suppressor LKB1 . SIK expression is induced during cardiogenesis and skeletal muscle differentiation ( Ruiz et al., 1994 ) or in adrenal glands, leading to steroidogenesis ( Okamoto et al., 2004 ) .
We uncover a new functional role of SIK in the TGF ␤ pathway. SIK induction is necessary for physiological TGF ␤ signaling. Ubiquitin promotes association of SIK to Smad7, which down-regulates ALK5. Thus, SIK defi nes a new negativefeedback loop initiated by incoming Smad signals.
Results and discussion TGF ␤ induces SIK in a Smad-dependent manner
We have reported Smad4-dependant gene profi les in response to TGF ␤ 1 or bone morphogenetic protein (BMP) 7 using human S ignal transduction by transforming growth factor ␤ (TGF ␤ ) coordinates physiological responses in diverse cell types. TGF ␤ signals via type I and type II receptor serine/threonine kinases and intracellular Smad proteins that regulate transcription. Strength and duration of TGF ␤ signaling is largely dependent on a negativefeedback program initiated during signal progression. We have identifi ed an inducible gene target of TGF ␤ /Smad signaling, the salt-inducible kinase (SIK), which negatively regulates signaling together with Smad7. SIK and Smad7 form a complex and cooperate to down-regulate the activated type I receptor ALK5. We further show that both the kinase and ubiquitin-associated domain of SIK are required for proper ALK5 degradation, with ubiquitin functioning to enhance SIK-mediated receptor degradation. Loss of endogenous SIK results in enhanced gene responses of the fi brotic and cytostatic programs of TGF ␤ . We thus identify in SIK a negative regulator that controls TGF ␤ receptor turnover and physiological signaling.
SIK associates and cooperates
with Smad7 for ALK5 down-regulation Down-regulation of ALK5 is mediated by Smad7 (for review see Itoh and ten Dijke, 2007 ) . We reasoned that SIK could associate directly with ALK5 or Smad7. Coimmunoprecipitation assays showed that SIK formed complexes with both ALK5 and Smad7 ( Fig. 3, A and B ) . [ I D ] F I G 3 [ / I D ] To detect SIK -ALK5 complexes, we had to achieve low SIK expression and high CA-ALK5 levels, which resulted in active ALK5 signaling with small effects on receptor down-regulation. SIK bound stronger to the Smad7 linker and C-terminal (Mad homology 2) domains than to its N-terminal domain ( Fig. 3 B ) . When endogenous human ALK5, Smad7, and SIK were immunoprecipitated from HaCaT lysates, SIK coprecipitated primarily with Smad7 and weakly with breast carcinoma MDA-MB-468 cells that lack both Smad4 gene copies ( Kowanetz et al., 2004 ) . After reconstitution with Smad4, TGF ␤ 1 or BMP7 rapidly induced SIK mRNA, followed by slow decrease ( Fig. 1, A and B ) . [ I D ] F I G 1 [ / I D ] In human HaCaT keratinocytes, TGF ␤ 1 induced and sustained SIK mRNA and protein levels ( Fig. 1, C and D ; and Fig. S1 A, available at http://www.jcb .org/cgi/content/full/jcb.200804107/DC1). Endogenous TGF ␤ 1-induced SIK protein showed punctate nuclear, cytoplasmic, and peripheral localization ( Fig. 1 E ) . SIK represents a new gene target of TGF ␤ /BMP7 Smad signaling. Interestingly, the clusters ( Fig. 3 D , insets) . Thus, SIK, Smad7, and ALK5 must form complexes in cytoplasmic regions proximal to the plasma membrane.
To verify the cooperation of Smad7 and SIK in negatively regulating TGF ␤ signaling, we measured the effects of SIK and Smad7 on the transcriptional induction of a Smad3/Smad4-specifi c promoter-reporter, CAGA 12 , by TGF ␤ 1 ( Fig. 3 E ) . SIK enhanced the inhibitory effect of Smad7 by more than twofold. Knockdown of endogenous Smad7 stabilized and rescued CA-ALK5 down-regulation by SIK, even though Smad7 depletion led to increased SIK levels ( Fig. 3 F ) . Thus, SIK mediates down-regulation of signaling ALK5 receptor in a Smad7-dependent manner. ALK5 ( Fig. 3 C ) , confi rming the evidence with transfected proteins. Thus, protein complexes between endogenous SIK, Smad7, and ALK5 occur in vivo.
Smad7 resides in the nucleus and moves to the cytoplasm in response to TGF-␤ (for review see Itoh and ten Dijke, 2007 ) . SIK also resides in both nucleus and cytoplasm, and its localization is regulated by hormones in adrenal cells or by the 14 -3-3 adaptor ( Okamoto et al., 2004 ; Al-Hakim et al., 2005 ) . In transfected TGF ␤ -sensitive Mv1Lu cells, SIK localized in nuclei and cytoplasm with pronounced punctate distribution proximal to the plasma membrane ( Fig. 3 D ) , which is similar to endogenous SIK ( Fig. 1 E ) . Colocalization of SIK, CA-ALK5, and Smad7 was primarily observed in peripheral . SIK readily coprecipitated ubiqui tinated proteins of diverse sizes, confi rming that they were distinct from ubiquitinated SIK. Wild-type and SIK-K56R bound to ubiquitinated proteins, whereas SIK-⌬ UBA or a mutant lacking both kinase and UBA domains ( ⌬ N) did not, suggesting that the SIK UBA domain is needed for binding to polyubiquitinated proteins ( Fig. 4 C ) . C-terminal deletion of SIK, after its UBA domain, had no effect on binding ubiquitinated proteins ( Fig. 4 C ) . Thus, SIK can associate with ubiquitinated proteins in cells.
Obvious ubiquitinated protein candidates to which SIK could bind were ALK5 and Smad7. Accordingly, the SIK -Smad7 complex was enhanced by coexpressing ubiquitin, whereas deletion of the UBA domain of SIK prohibited such enhancement ( Fig. 4 D ) . A slow migrating SIK form was obvious in complex with Smad7 ( Fig. 4 D , asterisk) , which may represent ubiquitinated SIK. In contrast, neither ubiquitin nor UBA domain deletion had any effect on SIK -ALK5 complexes (Fig. S2 B) . Ubiquitin therefore enhances association between SIK and Smad7, and the SIK UBA domain mediates formation of this ternary complex.
The SIK UBA domain was recently shown to not bind ubiquitin but to modulate SIK kinase activity in vitro ( Jaleel et al., 2006 ) .
Ubiquitin and the UBA domain modulate ALK5 regulation by SIK
We examined whether ubiquitin affected the ability of SIK to facilitate ALK5 degradation ( Fig. 4 A ) . [ 
I D ] F I G 4 [ / I D ]
Ubiquitin significantly enhanced the potency of CA-ALK5 down-regulation by SIK. A K48R ubiquitin mutant completely blocked this down-regulation. This implies that polyubiquitin chain formation via lysine 48 affects ALK5 degradation, which is compatible with a proteasome-dependent mechanism and inhibition of ALK5 degradation by LLnL ( Fig. 2 D ) .
We examined SIK localization in relation to ubiquitin in Mv1Lu cells ( Fig. 4 B ) . SIK distributed in nuclei, cytoplasm, and prominent peripheral structures, SIK-K56R showed more cytoplasmic enrichment, and both colocalized with cytoplasmic ubiquitin clusters. SIK lacking its UBA domain showed no colocalization, as it distributed diffusely in the cytoplasm, suggesting that SIK-ubiquitin clusters depend on the integrity of the UBA domain. These punctate structures were also enriched in 19S and 20S proteasomes (unpublished data).
We then expressed SIK and ubiquitin in different pools of cells before immunoprecipitation to measure association of SIK with ubiquitinated proteins but not SIK ubiquitination, per se how TGF ␤ receptor signaling is negatively regulated ( Fig. 5 F ) . SIK joins Smad7 in the negative-feedback loop of TGF ␤ signaling (for review see Itoh and ten Dijke, 2007 ) . SIK and Smad7 interact, and ubiquitin enhances their complex. SIK also binds to ALK5 and down-regulates the receptor in a Smad7-dependent manner. This model applies to various epithelial cell models that are highly sensitive to TGF ␤ including keratinocytes and lung cells. Our study emphasizes the role of ubiquitin and proteasomes in regulation of TGF ␤ signaling by SIK. Our data also support a role for the kinase activity of SIK ( Fig. 2 D ) . This offers the fi rst evidence for a kinase/ubiquitin binding protein being involved in the down-regulation of a signaling receptor. Identifying possible SIK substrates within the ALK5 -Smad7 complex and explaining their functional role in regulation of TGF ␤ signaling will be important. We provide evidence for lysosomal degradation of TGF ␤ receptors ( Fig. 2 C ) . This is a relatively unexplored step during TGF ␤ receptor internalization. TGF ␤ receptor ubiquitination and proteasomal degradation is often reported (for review see Itoh and ten Dijke, 2007 ) . A lysosomal pathway of receptor-ligand degradation would better fit to the classical mechanisms of receptor internalization and degradation. During this process, ubiquitin and proteasomes might act as intermediate processors of TGF ␤ receptor traffi cking from the plasma membrane to the lysosome.
Evolutionary conservation of SIK from humans to C. elegans , and functional conservation of SIK as a regulator of homeostatic (this study) and developmental ( Maduzia et al., 2005 ) We also failed in demonstrating in vitro binding of recombinant mono-or oligoubiquitin chains to SIK (unpublished data). SIK immunopurifi ed from mammalian cells clearly bound to ubiquitinated proteins via its UBA domain ( Fig. 4 C and Fig. S2 A) . This could refl ect an in vivo modifi cation or the requirement for another binding protein. Further studies will reveal the mechanism by which ubiquitin and the SIK UBA domain regulate its own function.
SIK negatively regulates TGF ␤ signaling
Stimulation of cells after endogenous SIK depletion enhanced the potency of TGF-␤ signaling ( Fig. 5, A and B ) . . We also confi rmed that SIK knockdown enhanced the magnitude of endogenous PAI-1 and p21 protein accumulation in response to TGF ␤ 1 ( Fig. 5 C ) . Finally, protein levels and pericellular localization of fi bronectin, another TGF ␤ gene target from the fi brotic program, augmented signifi cantly after depleting SIK ( Fig. 5, D and E ) . Thus, induction of SIK by TGF ␤ represents a central step in negative regulation of TGF ␤ signaling.
The identifi cation of SIK as an immediate early gene induced by the Smad pathway led to important new insights into in processes of TGF ␤ signaling and receptor down-regulation. Thus, SIK being a component of the T ␤ R -Smad7 complex provides a nodal point for crosstalk of the TGF ␤ pathway with LKB1 or AMP-activated protein kinase pathways. SIK therefore opens a new window for the elucidation of the process of downregulation of serine/threonine kinase receptors.
pathways guided by TGF ␤ signaling opens new territories for exploration of such pathways across species. Characterizing the role of the Drosophila melanogaster SIK orthologue will greatly benefi t this cause.
Because SIK is activated by the tumor suppressor kinase LKB1 ( Alessi et al., 2006 ) , our study suggests a role of LKB1 
Transient transfections
HaCaT cells were transfected with siRNAs via Lipofectamine 2000 (Invitrogen) or SiLentFect (Bio-Rad Laboratories), COS1 and Mv1Lu cells via Lipofectamine, and HEK293T and HepG2 cells via calcium phosphate as previously described ( Kowanetz et al., 2004 ) . 24 h after transfection, cells were stimulated with TGF-␤ 1 as indicated in the fi gures.
RT-PCR
Total HaCaT or MDA-MB-468 RNA was analyzed by quantitative or semiquantitative RT-PCR as previously described ( Niimi et al., 2007 ) . PCR primers are listed in Tables I and II , 
Materials and methods

Reagents
HaCaT keratinocytes, MDA-MB-468, HEK293T and HepG2 carcinoma, COS1 and Mv1Lu cells, and culture conditions were as previously described ( Kowanetz et al., 2004 ; Mor é n et al., 2005 ) . Recombinant TGF-␤ 1 was obtained from PeproTech. Anti -␤ -tubulin (T8535) and anti-Flag (M5) antibodies were obtained from Sigma-Aldrich; anti-GFP (A11122) from Invitrogen; anti -PAI-1 and anti-p21 (Cip1/WAF1) from BD Biosciences; anti-HA (Y-11), anti-T ␤ RI (V-22), and anti -␣ -tubulin (TU-02) from Santa Cruz Biotechnology, Inc.; rabbit polyclonal anti -human SIK (988, raised against peptide CEEQDTQESLPSSTGRR mapping C-terminally from the UBA domain), antiSmad7, and mouse monoclonal anti-myc (9E10) were made in house; rabbit polyclonal anti-CIN85(CT) was from I. Dikic (Goethe University, Frankfurt, Germany); secondary antibodies coupled to HRP from GE Healthcare; secondary antibodies coupled to FITC and TRITC from Dako; Alexa Fluor 546 from Invitrogen; and AMCA7 (7-amino-4-methylcoumarin-3-acetic acid) from Jackson ImmunoResearch Laboratories.
Human SIK -specifi c siRNA, ON-TARGET plus SMARTpool reagent L-003959-00, and control siRNA against the luciferase reporter vector pGL2 ( X65324 ) were from Thermo Fisher Scientifi c. An EST clone BG719047 of human SIK complete cDNA was obtained from H. Takemori and M. Okamoto (National Institute of Biomedical Innovation, Osaka, Japan). The cDNA was fused to a Flag, 6myc, and GFP creating pcDNA3-Flag-hSIK, pcDNA3-6myc-hSIK, and pEGFP-hSIK. The SIK ATP binding site mutant K56R was created by the Quick-Change mutagenesis kit (Stratagene). Deletion mutants SIK-⌬ UBA, SIK (K56R)-⌬ UBA, SIK-⌬ C, and SIK-⌬ N were created using a PCR-based strategy and were subcloned in pcDNA3-Flag and pEGFP. DNA constructs were sequence verifi ed. A previously published reference, the NCBI database accession number, or the Ensembl database transcript (ENST) number is indicated.
